TAOPING INC (TAOP)

VGG8675V1278 - Common Stock

0.4078  +0.09 (+28.64%)

After market: 0.3723 -0.04 (-8.71%)

Fundamental Rating

2

Taking everything into account, TAOP scores 2 out of 10 in our fundamental rating. TAOP was compared to 83 industry peers in the IT Services industry. Both the profitability and financial health of TAOP have multiple concerns. TAOP is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

TAOP had positive earnings in the past year.
In the past year TAOP has reported a negative cash flow from operations.
TAOP had negative earnings in each of the past 5 years.
TAOP had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 4.99%, TAOP is doing good in the industry, outperforming 65.43% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.73%, TAOP is in the better half of the industry, outperforming 69.14% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.43%, TAOP is doing good in the industry, outperforming 61.73% of the companies in the same industry.
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROIC 4.43%
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TAOP has a Profit Margin (3.99%) which is comparable to the rest of the industry.
With a Operating Margin value of 3.18%, TAOP perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
With a Gross Margin value of 21.39%, TAOP is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
TAOP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%

2

2. Health

2.1 Basic Checks

TAOP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TAOP has been increased compared to 1 year ago.
The number of shares outstanding for TAOP has been increased compared to 5 years ago.
The debt/assets ratio for TAOP is higher compared to a year ago.

2.2 Solvency

TAOP has an Altman-Z score of -6.34. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
TAOP has a Altman-Z score of -6.34. This is amonst the worse of the industry: TAOP underperforms 92.59% of its industry peers.
TAOP has a Debt/Equity ratio of 0.52. This is a neutral value indicating TAOP is somewhat dependend on debt financing.
TAOP has a Debt to Equity ratio (0.52) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -6.34
ROIC/WACC0.6
WACC7.38%

2.3 Liquidity

TAOP has a Current Ratio of 1.50. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
TAOP's Current ratio of 1.50 is in line compared to the rest of the industry. TAOP outperforms 48.15% of its industry peers.
A Quick Ratio of 1.33 indicates that TAOP should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.33, TAOP is doing worse than 61.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.33

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.29% over the past year.
Looking at the last year, TAOP shows a very strong growth in Revenue. The Revenue has grown by 37.49%.
TAOP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.40% yearly.
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.8%
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Sales Q2Q%28.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.65 indicates a rather cheap valuation of TAOP.
Based on the Price/Earnings ratio, TAOP is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
TAOP is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.65
Fwd PE N/A

4.2 Price Multiples

97.53% of the companies in the same industry are more expensive than TAOP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.55

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TAOP!.
Industry RankSector Rank
Dividend Yield N/A

TAOPING INC

NASDAQ:TAOP (12/20/2024, 8:00:00 PM)

After market: 0.3723 -0.04 (-8.71%)

0.4078

+0.09 (+28.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-07 2022-09-07/bmo
Earnings (Next)N/A N/A
Inst Owners4.47%
Inst Owner Change-10.81%
Ins Owners8.94%
Ins Owner ChangeN/A
Market Cap2.70M
Analysts82.86
Price TargetN/A
Short Float %1.26%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.65
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.17
EV/EBITDA 0.55
EPS(TTM)0.63
EY154.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS6.43
BVpS2.39
TBVpS2.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROCE 8.55%
ROIC 4.43%
ROICexc 4.52%
ROICexgc 4.52%
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
FCFM N/A
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%
F-Score5
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 53.09%
Cap/Sales 3.34%
Interest Coverage 1.82
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.33
Altman-Z -6.34
F-Score5
WACC7.38%
ROIC/WACC0.6
Cap/Depr(3y)123.42%
Cap/Depr(5y)94.82%
Cap/Sales(3y)22.91%
Cap/Sales(5y)19.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Sales Q2Q%28.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y166.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.5%
OCF growth 3YN/A
OCF growth 5YN/A